معرفی
Danielle N Larson serves as Assistant Professor of Neurology specializing in Movement Disorders at Northwestern University's Feinberg School of Medicine, with clinical expertise in Parkinson's disease, Huntington's disease, and tic disorders management through botulinum toxin therapy.
Her educational trajectory includes:
- BA from Boston College (2010)
- MD from Tufts University School of Medicine (2014)
- Internal Medicine Intern at Northwestern University (2015)
- Neurology Resident at Northwestern University (2018)
- Movement Disorders Fellow at Northwestern University (2020)
Dr. Larson's research demonstrates significant focus on health equity in movement disorders, particularly addressing barriers to Parkinson's research participation among underrepresented populations and telemedicine implementation during global health crises. Her work bridges clinical trials with patient-reported outcomes to develop inclusive therapeutic approaches for neurodegenerative conditions.
Recent publications reveal growing emphasis on systemic lupus-related movement disorders and scalable inclusivity frameworks like the FIRE-UP PD initiative, reflecting dual priorities of expanding treatment access while advancing gene therapy research for Parkinson's disease.
Her distinguished recognition includes:
- Visiting Mentorship Award, Parkinson’s Study Group (2019)
- Innovation Challenge Grant Winner, Northwestern Medicine (2019)
- AAN Quality and Safety Award (2019)
- Multiple travel grants from Parkinson's and Huntington's research consortia
- Marcella Marcinek Award from Northwestern University (2017)
Dr. Larson currently leads two major clinical trials: a Phase 1/2a gene therapy study (PR001A) for GBA1-mutation Parkinson's patients and a Phase IIb prasinezumab trial for early-stage Parkinson's, demonstrating her commitment to translational research from bench to bedside. She maintains active membership in the Parkinson's Study Group, Huntington's Study Group, and Movement Disorder Society to foster collaborative innovation.
